American Shared Hospital Services (NYSEAMERICAN:AMS) Earns Hold Rating from Analysts at StockNews.com

Posted by Scott Moore on Aug 9th, 2024

StockNews.com started coverage on shares of American Shared Hospital Services (NYSEAMERICAN:AMS – Free Report) in a research note released on Monday morning. The firm issued a hold rating on the stock.

American Shared Hospital Services Stock Performance

AMS opened at $3.01 on Monday. The company has a debt-to-equity ratio of 0.49, a quick ratio of 1.98 and a current ratio of 1.98. The company has a market cap of $19.05 million, a P/E ratio of 37.63 and a beta of 0.70. American Shared Hospital Services has a 1 year low of $2.16 and a 1 year high of $3.69.

American Shared Hospital Services (NYSEAMERICAN:AMS – Get Free Report) last released its quarterly earnings results on Tuesday, May 14th. The company reported $0.02 EPS for the quarter, missing analysts’ consensus estimates of $0.03 by ($0.01). American Shared Hospital Services had a net margin of 2.50% and a return on equity of 4.29%. The business had revenue of $5.22 million for the quarter, compared to the consensus estimate of $5.01 million. Analysts expect that American Shared Hospital Services will post 0.29 EPS for the current fiscal year.

Institutional Inflows and Outflows

An institutional investor recently bought a new position in American Shared Hospital Services stock. Empowered Funds LLC acquired a new stake in shares of American Shared Hospital Services (NYSEAMERICAN:AMS – Free Report) during the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm acquired 10,468 shares of the company’s stock, valued at approximately $31,000. Empowered Funds LLC owned about 0.17% of American Shared Hospital Services at the end of the most recent reporting period. 23.16% of the stock is owned by hedge funds and other institutional investors.

About American Shared Hospital Services

(Get Free Report)

American Shared Hospital Services provides stereotactic radiosurgery and advanced radiation therapy equipment. It operates in two segments, Medical Equipment Leasing, and Retail. The company offers radiosurgery equipment for the Gamma Knife stereotactic radiosurgery, a non-invasive procedure to treat malignant and benign brain tumors, and arteriovenous malformations, as well as for trigeminal neuralgia.